Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ellsworth

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Analytical and Bioanalytical Chemistry|November 26, 2008
Screening phosphatidylcholine biomarkers in mouse liver extracts from a hypercholesterolemia study using ESI-MS and chemometricsLi Yang, Richard Bennett, John Strum, et al.
Papillomavirus Research (Amsterdam, Netherlands)|May 29, 2018
A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected menG B Ellsworth, S Y Lensing, C B Ogilvie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2021
Xpert HPV as a Screening Tool for Anal Histologic High-Grade Squamous Intraepithelial Lesions in Women Living With HIVGrant B Ellsworth, Elizabeth A Stier, Elizabeth Y Chiao, et al.
Life Science Alliance|December 28, 2020
Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progressionAndré F Rendeiro, Joseph Casano, Charles Kyriakos Vorkas, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2020
Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progressionAndré F Rendeiro, Joseph Casano, Charles Kyriakos Vorkas, et al.
Vaccine|July 3, 2025
Design of a multicenter, randomized, double-blinded, placebo-controlled phase III trial evaluating the 9-valent human papillomavirus (HPV) vaccine to prevent persistent oral HPV infection in men living with human immunodeficiency virus: ULACNet trial 201Anna R Giuliano, Anna Beltrame, Luisa L Villa, et al.
The Journal of Infection|May 3, 2026
Genotype Distribution of Human Papillomavirus (HPV) Types in Oral Gargle Specimens among Men Living with HIV in Mexico, Brazil, and Puerto Rico: a Cross-Sectional StudyAnna Beltrame, Anna R Giuliano, Luisa L Villa, et al.
Scientific Reports|May 29, 2026
Alcohol consumption and oral human papillomavirus infection among men living with HIV: a cross-sectional study from the ULACNet 201 trialAnna Beltrame, Luisa L Villa, Eduardo Lazcano-Ponce, et al.
Open Forum Infectious Diseases|June 16, 2025
Prognostic Factors of Physical Function Decline Among Middle-Aged Adults With HIVGrace L Kulik, Triin Umbleja, Todd T Brown, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2022
Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United StatesMarkella V Zanni, Borek Foldyna, Sara McCallum, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Analytical and Bioanalytical Chemistry|November 26, 2008
Screening phosphatidylcholine biomarkers in mouse liver extracts from a hypercholesterolemia study using ESI-MS and chemometricsLi Yang, Richard Bennett, John Strum, et al.
Papillomavirus Research (Amsterdam, Netherlands)|May 29, 2018
A delayed dose of quadrivalent human papillomavirus vaccine demonstrates immune memory in HIV-1-infected menG B Ellsworth, S Y Lensing, C B Ogilvie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2021
Xpert HPV as a Screening Tool for Anal Histologic High-Grade Squamous Intraepithelial Lesions in Women Living With HIVGrant B Ellsworth, Elizabeth A Stier, Elizabeth Y Chiao, et al.
Life Science Alliance|December 28, 2020
Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progressionAndré F Rendeiro, Joseph Casano, Charles Kyriakos Vorkas, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2020
Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progressionAndré F Rendeiro, Joseph Casano, Charles Kyriakos Vorkas, et al.
Vaccine|July 3, 2025
Design of a multicenter, randomized, double-blinded, placebo-controlled phase III trial evaluating the 9-valent human papillomavirus (HPV) vaccine to prevent persistent oral HPV infection in men living with human immunodeficiency virus: ULACNet trial 201Anna R Giuliano, Anna Beltrame, Luisa L Villa, et al.
The Journal of Infection|May 3, 2026
Genotype Distribution of Human Papillomavirus (HPV) Types in Oral Gargle Specimens among Men Living with HIV in Mexico, Brazil, and Puerto Rico: a Cross-Sectional StudyAnna Beltrame, Anna R Giuliano, Luisa L Villa, et al.
Scientific Reports|May 29, 2026
Alcohol consumption and oral human papillomavirus infection among men living with HIV: a cross-sectional study from the ULACNet 201 trialAnna Beltrame, Luisa L Villa, Eduardo Lazcano-Ponce, et al.
Open Forum Infectious Diseases|June 16, 2025
Prognostic Factors of Physical Function Decline Among Middle-Aged Adults With HIVGrace L Kulik, Triin Umbleja, Todd T Brown, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 14, 2022
Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United StatesMarkella V Zanni, Borek Foldyna, Sara McCallum, et al.
Pageof 4